Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “de Novo”

1,166 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,166 results

Testing effectiveness (Phase 2)Ended earlyNCT03781414
What this trial is testing

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension

Who this might be right for
Liver Transplant Rejection
Novartis Pharmaceuticals 129
Testing effectiveness (Phase 2)Study completedNCT00053287
What this trial is testing

Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Case Comprehensive Cancer Center 42
Post-approval studies (Phase 4)WithdrawnNCT00151385
What this trial is testing

Study Evaluating Inhibitor Specificity in Hemophilia A

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer
Post-approval studies (Phase 4)Study completedNCT01498887
What this trial is testing

Efficacy of Fingolimod in de Novo Patients Versus Fingolimod in Patients Previously Treated With a First Line Disease Modifying Therapy

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 347
Testing effectiveness (Phase 2)Study completedNCT01666951
What this trial is testing

Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant

Who this might be right for
Renal Failure
Veloxis Pharmaceuticals 36
Early research (Phase 1)Study completedNCT04702737
What this trial is testing

AMG 757 in Participants With Neuroendocrine Prostate Cancer

Who this might be right for
Neuroendocrine Prostate Cancer
Amgen 41
Testing effectiveness (Phase 2)Study completedNCT00245037
What this trial is testing

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
OHSU Knight Cancer Institute 147
Post-approval studies (Phase 4)Study completedNCT00656695
What this trial is testing

Comparisone of Iminoral Versus Neoral in Prevention of Acute Rejection in Renal Transplantation

Who this might be right for
End Stage Renal DiseaseRenal Transplantation
Imam Khomeini Hospital 208
Post-approval studies (Phase 4)Study completedNCT01601821
What this trial is testing

Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + Corticosteroids

Who this might be right for
Inflammation
Pfizer 245
Testing effectiveness (Phase 2)Study completedNCT00578448
What this trial is testing

Belatacept Pharmacokinetic Trial in Renal Transplantation

Who this might be right for
Renal Transplantation
Bristol-Myers Squibb 14
Not applicableStudy completedNCT00614848
What this trial is testing

The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions

Who this might be right for
Coronary Artery DiseaseArterial Occlusive DiseasesCoronary Disease+6 more
Medtronic Vascular 1,200
Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Testing effectiveness (Phase 2)Study completedNCT00934752
What this trial is testing

De Novo Pilot Study, Lutonix Catheter in Conjunction With Bare Metal Stenting for Treatment of Coronary De Novo Lesions

Who this might be right for
Coronary Artery Stenosis
C. R. Bard 24
Testing effectiveness (Phase 2)Looking for participantsNCT07053085
What this trial is testing

Surgery and Radiotherapy in People With Breast Cancer

Who this might be right for
Metastatic Breast CancerHER2-positive Breast Cancer
Memorial Sloan Kettering Cancer Center 162
Not applicableEnded earlyNCT00255684
What this trial is testing

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
University of Rochester 16
Testing effectiveness (Phase 2)Ended earlyNCT00555048
What this trial is testing

Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)UnknownNCT02753647
What this trial is testing

Chidamide Plus R-CHOP in Elderly DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma
Ruijin Hospital 49
Not applicableStudy completedNCT01866215
What this trial is testing

Effects of Exercise on Fructose Metabolism

Who this might be right for
Healthy Subjects
University of Lausanne 8
Not applicableNot Yet RecruitingNCT06300268
What this trial is testing

Advapro Coronary Stent System in Coronary Artery Diseased Patients.

Who this might be right for
Coronary Artery DiseaseDe Novo Stenosis LesionCoronary Stent Implantation
Advanced MedTech Solutions Pvt. Ltd. 120
Early research (Phase 1)Study completedNCT00376480
What this trial is testing

Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Dana-Farber Cancer Institute 19
Load More Results